SELLAS Life Sciences Group Inc (FRA:RXK3) Stock News, Headlines & Updates
SELLAS Life Sciences Group Inc Stock News from GuruFocus
- 1
Jun 17, 2024
SELLAS Life Sciences Announces Positive Recommendation from the Independent Data Monitoring Committee of the Phase 3 REGAL Trial in Acute Myeloid Leukemia
Marketwired • 9:00am
Jun 10, 2024
SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r/r AML
Marketwired • 8:00am
May 14, 2024
SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update
Marketwired • 4:00pm
May 01, 2024
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
Marketwired • 8:01am
Apr 29, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news